세계의 의료 조사 시장 보고서(2025년)

Medical irradiation refers to the targeted use of radiation in treating diseases, particularly cancer, where controlled doses are applied to damage or destroy specific cells while minimizing their impact on healthy tissues. It is employed in diagnostic settings to produce images of internal structures or functions, facilitating the identification and diagnosis of various medical conditions.

The disease types of medical irradiation include trisomy 21, translocation medical irradiation, and mosaic medical irradiation. Trisomy 21 is a genetic condition characterized by the presence of an extra copy of chromosome 21, leading to Down syndrome. The treatment types are categorized into two categories such as diagnosis and therapy. The distribution channels include direct tenders, retail sales, and others. The end users are hospitals, clinics, homecare settings, therapy centers, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The disease types of medical irradiation include trisomy 21, translocation medical irradiation, and mosaic medical irradiation. Trisomy 21 is a genetic condition characterized by the presence of an extra copy of chromosome 21, leading to Down syndrome. The treatment types are categorized into two categories such as diagnosis and therapy. The distribution channels include direct tenders, retail sales, and others. The end users are hospitals, clinics, homecare settings, therapy centers, and others.

The medical irradiation market size has grown rapidly in recent years. It will grow from $1.69 billion in 2024 to $1.96 billion in 2025 at a compound annual growth rate (CAGR) of 16.4%. The growth in the historic period can be attributed to increasing prevalence of cancer, growing adoption of radiation therapy, rising geriatric population, increasing demand for non-invasive treatment options, and expansion of healthcare infrastructure.

The medical irradiation market size is expected to see rapid growth in the next few years. It will grow to $3.32 billion in 2029 at a compound annual growth rate (CAGR) of 14.1%. The growth in the forecast period can be attributed to government initiatives to improve cancer care, growing awareness about early detection and treatment, rising disposable income, increasing focus on precision medicine, and rising demand for targeted cancer therapies. Major trends in the forecast period include integration of artificial intelligence in radiation therapy, online adaptive radiotherapy, popularity of hypo fractionated radiation therapy, proton therapy for precise cancer treatment, and shift towards image-guided radiation therapy (IGRT).

The forecast of 14.1% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. cancer treatment centers by inflating prices of sterilization equipment and therapeutic radiation modules developed in Sweden and Switzerland, resulting in delayed sterilization processes and higher oncology department costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of cancer is expected to drive the growth of the medical irradiation market in the coming years. Cancer is characterized by uncontrolled cell growth, affecting various organs and leading to significant morbidity and mortality globally. Medical irradiation plays a vital role in cancer treatment, using targeted radiation to damage or destroy cancer cells while minimizing harm to healthy tissues. For example, a report by the Leukemia & Lymphoma Society, a US-based non-profit health organization, predicts that in 2023, 184,720 individuals in the US will be diagnosed with leukemia, lymphoma, or myeloma. Additionally, approximately 1,958,310 new cancer cases are expected to be diagnosed in the US in 2023, with leukemia, lymphoma, and myeloma accounting for 9.4% of those cases. As a result, the high incidence of cancer is fueling the growth of the medical irradiation market.

Major companies operating in the medical irradiation market are developing innovative solutions, such as the Premium Dual-Energy Mobile System, to gain a competitive advantage. A Premium Dual-Energy Mobile System is a high-end medical imaging device that integrates dual-energy technology for enhanced diagnostic capabilities while offering mobility across different clinical settings, providing advanced imaging solutions at the point of care. For instance, in July 2023, KA Imaging, a Canada-based manufacturer, unveiled its Reveal Mobi Pro dual-energy mobile X-ray system. The Reveal Mobi Pro is a comprehensive mobile X-ray solution that combines SpectralDR technology with KA Imaging's Reveal 35C detector. At the bedside, Reveal's capacity to take dual-energy and conventional images simultaneously with a single exposure enhances patient and hospital results while safeguarding income by lowering outflows.

In October 2022, Halma plc, a UK-based technology company, acquired IZI medical products for £138 million ($146 million). Through the acquisition, Halma aims to diversify its portfolio of physician-led innovations, enhancing its ability to meet patient demands and deliver high-quality healthcare services. IZI Medical Products is a US-based manufacturer of radiation therapy, diagnostic radiology, and image-guided surgery medical devices.

Major companies operating in the medical irradiation market are Hitachi Ltd., Thermo Fisher Scientific Inc., Toshiba Corporation, Siemens Healthcare GmbH, Koninklijke Philips N.V., GE Healthcare Company, Mayo Clinic Health System, Canon Medical Systems R&D (Dalian) Co. Ltd., PerkinElmer Inc., Varian Medical Systems Inc., Elekta AB, Accuray Incorporated, Ion Beam Applications S.A., Brainlab AG, ViewRay Technologies Inc., Mevion Medical Systems Inc., RaySearch Laboratories AB, NTP Radioisotopes SOC Ltd., RefleXion Medical Inc., Vision RT Ltd., Sun Nuclear Corporation, IZI Medical Products LLC, Eckert & Ziegler BEBIG GmbH, C-RAD AB, Panacea Medical Technologies Pvt. Ltd., Standard Imaging Inc., CIVCO Radiotherapy Inc., IntraOp Medical Corporation, RTsafe Solutions Ltd., ASG Superconductors S.p.A., Mirada Medical Corporation

North America was the largest region in the medical irradiation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical irradiation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the medical irradiation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The medical irradiation market includes revenues earned by entities by providing services such as diagnostic imaging services, radiation therapy, radiopharmaceutical and radiation safety, and dosimetry services. The market value includes the value of related goods sold by the service provider or included within the service offering. The medical irradiation market consists of sales of products such as radiation therapy equipment, diagnostic imaging devices, radiopharmaceuticals, and nuclear medicine devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Medical Irradiation Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on medical irradiation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for medical irradiation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The medical irradiation market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Disease Type: Trisomy 21; Translocation Medical Irradiation; Mosaic Medical Irradiation
• 2) By Treatment: Diagnosis; Therapy
• 3) By Distribution Channel: Direct Tender; Retail Sales; Other Distribution Channels
• 4) By End User: Hospital; Clinics; Homecare Setting; Therapy Centers; Other End-Users
• Subsegments:
• 1) By Trisomy 21: Prenatal Diagnosis; Postnatal Diagnosis
• 2) By Translocation Medical Irradiation: Acute Lymphoblastic Leukemia (ALL); Chronic Myeloid Leukemia (CML)
• 3) By Mosaic Medical Irradiation: Genetic Counseling; Diagnostic Imaging
• Companies Mentioned: Hitachi Ltd.; Thermo Fisher Scientific Inc.; Toshiba Corporation; Siemens Healthcare GmbH; Koninklijke Philips N.V.; GE Healthcare Company; Mayo Clinic Health System; Canon Medical Systems R&D (Dalian) Co. Ltd.; PerkinElmer Inc.; Varian Medical Systems Inc.; Elekta AB; Accuray Incorporated; Ion Beam Applications S.A.; Brainlab AG; ViewRay Technologies Inc.; Mevion Medical Systems Inc.; RaySearch Laboratories AB; NTP Radioisotopes SOC Ltd.; RefleXion Medical Inc.; Vision RT Ltd. ; Sun Nuclear Corporation; IZI Medical Products LLC; Eckert & Ziegler BEBIG GmbH; C-RAD AB; Panacea Medical Technologies Pvt. Ltd.; Standard Imaging Inc.; CIVCO Radiotherapy Inc.; IntraOp Medical Corporation; RTsafe Solutions Ltd.; ASG Superconductors S.p.A.; Mirada Medical Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Medical Irradiation Market Characteristics

3. Medical Irradiation Market Trends And Strategies

4. Medical Irradiation Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Medical Irradiation Growth Analysis And Strategic Analysis Framework

• 5.1. Global Medical Irradiation PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Medical Irradiation Market Growth Rate Analysis
• 5.4. Global Medical Irradiation Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Medical Irradiation Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Medical Irradiation Total Addressable Market (TAM)

6. Medical Irradiation Market Segmentation

• 6.1. Global Medical Irradiation Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Trisomy 21
• Translocation Medical Irradiation
• Mosaic Medical Irradiation
• 6.2. Global Medical Irradiation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnosis
• Therapy
• 6.3. Global Medical Irradiation Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Direct Tender
• Retail Sales
• Other Distribution Channels
• 6.4. Global Medical Irradiation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital
• Clinics
• Homecare Setting
• Therapy Centers
• Other End-Users
• 6.5. Global Medical Irradiation Market, Sub-Segmentation Of Trisomy 21, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Prenatal Diagnosis
• Postnatal Diagnosis
• 6.6. Global Medical Irradiation Market, Sub-Segmentation Of Translocation Medical Irradiation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acute Lymphoblastic Leukemia (ALL)
• Chronic Myeloid Leukemia (CML)
• 6.7. Global Medical Irradiation Market, Sub-Segmentation Of Mosaic Medical Irradiation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Genetic Counseling
• Diagnostic Imaging

7. Medical Irradiation Market Regional And Country Analysis

• 7.1. Global Medical Irradiation Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Medical Irradiation Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Medical Irradiation Market

• 8.1. Asia-Pacific Medical Irradiation Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Medical Irradiation Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Medical Irradiation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Medical Irradiation Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Medical Irradiation Market

• 9.1. China Medical Irradiation Market Overview
• 9.2. China Medical Irradiation Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Medical Irradiation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Medical Irradiation Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Medical Irradiation Market

• 10.1. India Medical Irradiation Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Medical Irradiation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Medical Irradiation Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Medical Irradiation Market

• 11.1. Japan Medical Irradiation Market Overview
• 11.2. Japan Medical Irradiation Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Medical Irradiation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Medical Irradiation Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Medical Irradiation Market

• 12.1. Australia Medical Irradiation Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Medical Irradiation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Medical Irradiation Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Medical Irradiation Market

• 13.1. Indonesia Medical Irradiation Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Medical Irradiation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Medical Irradiation Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Medical Irradiation Market

• 14.1. South Korea Medical Irradiation Market Overview
• 14.2. South Korea Medical Irradiation Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Medical Irradiation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Medical Irradiation Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Medical Irradiation Market

• 15.1. Western Europe Medical Irradiation Market Overview
• 15.2. Western Europe Medical Irradiation Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Medical Irradiation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Medical Irradiation Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Medical Irradiation Market

• 16.1. UK Medical Irradiation Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Medical Irradiation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Medical Irradiation Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Medical Irradiation Market

• 17.1. Germany Medical Irradiation Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Medical Irradiation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Medical Irradiation Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Medical Irradiation Market

• 18.1. France Medical Irradiation Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Medical Irradiation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Medical Irradiation Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Medical Irradiation Market

• 19.1. Italy Medical Irradiation Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Medical Irradiation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Medical Irradiation Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Medical Irradiation Market

• 20.1. Spain Medical Irradiation Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Medical Irradiation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Medical Irradiation Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Medical Irradiation Market

• 21.1. Eastern Europe Medical Irradiation Market Overview
• 21.2. Eastern Europe Medical Irradiation Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Medical Irradiation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Medical Irradiation Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Medical Irradiation Market

• 22.1. Russia Medical Irradiation Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Medical Irradiation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Medical Irradiation Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Medical Irradiation Market

• 23.1. North America Medical Irradiation Market Overview
• 23.2. North America Medical Irradiation Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Medical Irradiation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Medical Irradiation Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Medical Irradiation Market

• 24.1. USA Medical Irradiation Market Overview
• 24.2. USA Medical Irradiation Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Medical Irradiation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Medical Irradiation Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Medical Irradiation Market

• 25.1. Canada Medical Irradiation Market Overview
• 25.2. Canada Medical Irradiation Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Medical Irradiation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Medical Irradiation Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Medical Irradiation Market

• 26.1. South America Medical Irradiation Market Overview
• 26.2. South America Medical Irradiation Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Medical Irradiation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Medical Irradiation Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Medical Irradiation Market

• 27.1. Brazil Medical Irradiation Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Medical Irradiation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Medical Irradiation Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Medical Irradiation Market

• 28.1. Middle East Medical Irradiation Market Overview
• 28.2. Middle East Medical Irradiation Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Medical Irradiation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Medical Irradiation Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Medical Irradiation Market

• 29.1. Africa Medical Irradiation Market Overview
• 29.2. Africa Medical Irradiation Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Medical Irradiation Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Medical Irradiation Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Medical Irradiation Market Competitive Landscape And Company Profiles

• 30.1. Medical Irradiation Market Competitive Landscape
• 30.2. Medical Irradiation Market Company Profiles
  • 30.2.1. Hitachi Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Toshiba Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Siemens Healthcare GmbH Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis

31. Medical Irradiation Market Other Major And Innovative Companies

• 31.1. GE Healthcare Company
• 31.2. Mayo Clinic Health System
• 31.3. Canon Medical Systems R&D (Dalian) Co. Ltd.
• 31.4. PerkinElmer Inc.
• 31.5. Varian Medical Systems Inc.
• 31.6. Elekta AB
• 31.7. Accuray Incorporated
• 31.8. Ion Beam Applications S.A.
• 31.9. Brainlab AG
• 31.10. ViewRay Technologies Inc.
• 31.11. Mevion Medical Systems Inc.
• 31.12. RaySearch Laboratories AB
• 31.13. NTP Radioisotopes SOC Ltd.
• 31.14. RefleXion Medical Inc.
• 31.15. Vision RT Ltd.

32. Global Medical Irradiation Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Medical Irradiation Market

34. Recent Developments In The Medical Irradiation Market

35. Medical Irradiation Market High Potential Countries, Segments and Strategies

• 35.1 Medical Irradiation Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Medical Irradiation Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Medical Irradiation Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer